EDA2R and cancer: In a recent study published in Nature, Bilgic et al. have elucidated a crucial role of Ectodysplasin A2 receptor (EDA2R) and its downstream effector, NF-κB-inducing kinase (NIK), in the pathogenesis of cancer cachexia.